Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.895 USD | -1.25% | +3.14% | -1.99% |
02/05 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.99% | 136.33Cr | |
+31.17% | 4.95TCr | |
+1.87% | 4.26TCr | |
+48.88% | 4.25TCr | |
-5.26% | 2.91TCr | |
+12.84% | 2.66TCr | |
-23.65% | 1.86TCr | |
+7.89% | 1.32TCr | |
+31.00% | 1.25TCr | |
+23.90% | 1.21TCr |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Morgan Stanley Cuts Vir Biotechnology's Price Target to $15 From $27, Maintains Equalweight Rating